1. Home
  2. CPT vs MEDP Comparison

CPT vs MEDP Comparison

Compare CPT & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Camden Property Trust

CPT

Camden Property Trust

HOLD

Current Price

$106.54

Market Cap

11.2B

Sector

Real Estate

ML Signal

HOLD

Logo Medpace Holdings Inc.

MEDP

Medpace Holdings Inc.

HOLD

Current Price

$470.71

Market Cap

12.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPT
MEDP
Founded
1993
1992
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Commercial Physical & Biological Resarch
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.2B
12.9B
IPO Year
1995
2016

Fundamental Metrics

Financial Performance
Metric
CPT
MEDP
Price
$106.54
$470.71
Analyst Decision
Buy
Hold
Analyst Count
18
13
Target Price
$117.26
$498.25
AVG Volume (30 Days)
974.0K
435.8K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
3.90%
N/A
EPS Growth
136.00
20.98
EPS
3.54
15.28
Revenue
$12,967,000.00
N/A
Revenue This Year
$0.46
$13.11
Revenue Next Year
$2.82
$7.51
P/E Ratio
$30.69
$30.76
Revenue Growth
81.69
N/A
52 Week Low
$97.17
$250.05
52 Week High
$124.32
$628.92

Technical Indicators

Market Signals
Indicator
CPT
MEDP
Relative Strength Index (RSI) 44.02 43.76
Support Level $105.24 $457.41
Resistance Level $111.94 $501.30
Average True Range (ATR) 1.94 17.34
MACD -0.15 7.68
Stochastic Oscillator 17.48 87.87

Price Performance

Historical Comparison
CPT
MEDP

About CPT Camden Property Trust

Camden Property Trust is a real estate investment trust engaged in the ownership, management, development, reposition, redevelopment, acquisition, and construction of multifamily apartment communities. It owned interests in, operated, or developing nearly 175 multifamily properties comprised of nearly 59,921 apartment homes across the United States.

About MEDP Medpace Holdings Inc.

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Share on Social Networks: